A disciplinary hearing panel has ruled Dr. Charles Hoffe, one of the first Canadian doctors to raise concerns about C19 jab injuries, will be able to contest his licensing body's assertion that the injections are 'safe and effective.'
"Oxaro had received $50.6 million in taxpayer money; $33.7 million has been spent on administrative costs, while injured Canadians received $16.9 million. Updated Health Canada figures released last week show the company has now received $54.1 million and spent $36.3 million on administration costs, with just $18.1 million paid to injured Canadians"
https://globalnews.ca/news/11407587/visp-program-phac-government/